Laipac, an internet of medical things (IoMT) developer, has has received CE IVD clearance for its LooK SPOT Covid-19 antigen rapid test. The test, which delivers real time results in five to eight minutes, is a smartphone-based diagnostic device with a lateral flow immunoassay. It detects the nucleocapsid protein from SARS-CoV-2 in nasal swabs from suspected Covid-19 patients in the first eight days of the symptom onset.
The Virginia Department of Health has extended its existing COVIDWISE technology by announcing the launch of COVIDWISE Express, an app-less technology that notifies users if they may have been exposed to the SARS-CoV-2 virus. COVIDWISE Express was launched last week and is similar to the COVIDWISE app launched in August, but does not require downloading. It is only available to iPhone users.
Eone Diagnomics Genome Center, a bio-healthcare company, announced that it has received official approval from the Ministry of Food and Drug Safety to export its Covid-19 rapid test kit. The EDGC COVID-19 Ag test detects proteins that contain viruses from nasal and phlegm swabs.
